Enzymatica AB (publ)
STO:ENZY
Intrinsic Value
The intrinsic value of one ENZY stock under the Base Case scenario is 1.87 SEK. Compared to the current market price of 4.12 SEK, Enzymatica AB (publ) is Overvalued by 55%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Enzymatica AB (publ)
Fundamental Analysis

Revenue & Expenses Breakdown
Enzymatica AB (publ)
Balance Sheet Decomposition
Enzymatica AB (publ)
Current Assets | 112m |
Cash & Short-Term Investments | 75.2m |
Receivables | 20.1m |
Other Current Assets | 16.7m |
Non-Current Assets | 83.2m |
Long-Term Investments | 2.6m |
PP&E | 14.4m |
Intangibles | 66.2m |
Other Non-Current Assets | 1k |
Free Cash Flow Analysis
Enzymatica AB (publ)
SEK | |
Free Cash Flow | SEK |
Earnings Waterfall
Enzymatica AB (publ)
Revenue
|
45.6m
SEK
|
Cost of Revenue
|
-14.9m
SEK
|
Gross Profit
|
30.7m
SEK
|
Operating Expenses
|
-82.8m
SEK
|
Operating Income
|
-52.1m
SEK
|
Other Expenses
|
-1.1m
SEK
|
Net Income
|
-53.2m
SEK
|
ENZY Profitability Score
Profitability Due Diligence
Enzymatica AB (publ)'s profitability score is 23/100. The higher the profitability score, the more profitable the company is.
Score
Enzymatica AB (publ)'s profitability score is 23/100. The higher the profitability score, the more profitable the company is.
ENZY Solvency Score
Solvency Due Diligence
Enzymatica AB (publ)'s solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Score
Enzymatica AB (publ)'s solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ENZY Price Targets Summary
Enzymatica AB (publ)
According to Wall Street analysts, the average 1-year price target for ENZY is 3.96 SEK with a low forecast of 2.71 SEK and a high forecast of 5.34 SEK.
Dividends
Current shareholder yield for ENZY is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one ENZY stock under the Base Case scenario is 1.87 SEK.
Compared to the current market price of 4.12 SEK, Enzymatica AB (publ) is Overvalued by 55%.